摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-methylbutyl phenyl ether | 14789-87-8

中文名称
——
中文别名
——
英文名称
1-methylbutyl phenyl ether
英文别名
o-di(sec-amyloxy)benzene;(Pentan-2-yloxy)benzene;pentan-2-yloxybenzene
1-methylbutyl phenyl ether化学式
CAS
14789-87-8
化学式
C11H16O
mdl
——
分子量
164.247
InChiKey
LIJRCJHHPRMIEX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    221.0±9.0 °C(Predicted)
  • 密度:
    0.913±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    12
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为产物:
    描述:
    乙酸苯酯正戊烷二叔丁基过氧化物 、 C28H33CuN2O4 作用下, 以 neat (no solvent) 为溶剂, 反应 24.0h, 生成 戊氧基苯1-ethylpropyl phenyl ether1-methylbutyl phenyl ether
    参考文献:
    名称:
    铜催化 sp3C-H 与酰基保护酚的醚化
    摘要:
    多种酰基保护的酚 AcOAr 参与底物 RH 的 sp3 CH 醚化,以 tBuOOtBu 作为氧化剂与铜 (I) β-二酮亚胺催化剂 [CuI] 一起得到烷基芳基醚 R-OAr。尽管 1°、2° 和 3° CH 键可以被官能化,但选择性研究表明优先构建受阻的 3° C-OAr 键。机理研究表明,β-二酮亚氨基铜 (II) 酚盐 [CuII]-OAr 在此 CO 键形成反应中起关键作用,通过 AcOAr 与 [CuI]-OtBu 中间体的酯交换反应形成 [CuI] 与 tBuOOtBu 反应。
    DOI:
    10.1021/jacs.6b09057
点击查看最新优质反应信息

文献信息

  • [EN] CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE<br/>[FR] INHIBITEURS DE LA CÉRAMIDE GALACTOSYLTRANSFÉRASE POUR LE TRAITEMENT DE MALADIES
    申请人:BIOMARIN PHARM INC
    公开号:WO2018118838A1
    公开(公告)日:2018-06-28
    Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.
    本文描述了化合物、制备这种化合物的方法、含有这种化合物的药物组合物和药物,以及使用这种化合物治疗或预防与酶神经鞘糖脂转移酶(CGT)相关的疾病或紊乱的方法,例如溶酶体贮积症。溶酶体贮积症的例子包括 Krabbe 病和白质变性白血病。
  • 9-(P-phenylazoanilino)-7-methyl-1H-imidazo[4,5-f]quinolines
    申请人:Morton-Norwich Products, Inc.
    公开号:US03947434A1
    公开(公告)日:1976-03-30
    A series of 9-(substituted amino)imidazo[4,5-f]quinolines are effective anthelmintic agents; particularly in respect to the tapeworm Hymenolepis nana.
    一系列9-(取代基)咪唑并[4,5-f]喹啉是有效的驱虫药物;特别对于绦虫Hymenolepis nana。
  • Amino alcohol compound
    申请人:Nishi Takahide
    公开号:US20070191468A1
    公开(公告)日:2007-08-16
    A pharmaceutical composition is provided that has a low toxicity, demonstrates superior physicochemical properties and pharmacokinetics, and has superior peripheral blood lymphocyte count lowering activity. The pharmaceutical composition contains a compound having general formula (I): [Chemical Formula 1] (wherein R 1 represents a methyl group or an ethyl group, R 2 represents a methyl group or an ethyl group, and R 3 represents a phenyl group substituted with 1 to 3 substituents selected from the group consisting of a halogen atom, a lower alkyl group, a cycloalkyl group, a lower alkoxy group, a halogeno lower alkyl group, a lower aliphatic acyl group and a cyano group), a pharmacologically acceptable salt thereof or a pharmacologically acceptable ester thereof.
    提供了一种低毒性、表现出优越的物理化学性质和药代动力学,并具有优越的外周血淋巴细胞计数降低活性的药物组合物。该药物组合物包含具有一般式(I)的化合物:[化学式1](其中R1代表甲基基团或乙基基团,R2代表甲基基团或乙基基团,R3代表苯基,该苯基被1至3个取自卤原子、较低烷基基团、环烷基团、较低烷氧基团、卤代较低烷基基团、较低脂肪酰基基团和基的取代基所取代),以及其药理学上可接受的盐或药理学上可接受的酯。
  • Catalytic C-H Bond Activation
    申请人:Georgetown University
    公开号:US20150321982A1
    公开(公告)日:2015-11-12
    Disclosed is a method for the transition metal-mediated oxidation of C—H bonds to form C—O or C—S bonds. The methods are useful for the formation of ethers (R—OR′) from alcohols, R′OH, and sp 3 -hybridized C—H bonds in substrates, R—H. Aryl or heteroaryl acetates may also be used for C—H to C-OAr bond formation. The methods are also useful in the preparation of C—S bonds from acetyl-protected thiols, MeC(O)SR, and disulfides, RSSR. Advantageously, the methods minimize reaction steps, the handling of oxidized intermediates, and environmental impact.
    本发明公开了一种过渡属介导的氧化C-H键形成C-O或C-S键的方法。该方法可用于从醇,R'OH和底物中的sp3杂化C-H键形成醚(R-OR')。芳基或杂环基乙酸酯也可用于C-H到C-OAr键的形成。该方法还可用于从乙酰保护的醇,MeC(O)SR和二硫化物,RSSR中制备C-S键。该方法具有反应步骤少,处理氧化中间体少,对环境的影响小的优点。
  • Method for producing an aromatic compound having an alkyl group with at least three carbon atoms
    申请人:TORAY INDUSTRIES, INC.
    公开号:EP0985649A2
    公开(公告)日:2000-03-15
    Aromatic compounds having an alkyl group with at least 3 carbon atoms are produced in a process comprising at least one of the following steps: (1) a step of contacting a starting material that contains an aromatic compound having a branched alkyl group with at least 3 carbon atoms, with a zeolite-containing catalyst in a liquid phase in the presence of hydrogen therein, thereby changing the position of the carbon atoms of the alkyl group bonding to the aromatic ring of the compound; (2) a step of contacting a starting material that contains an aromatic compound having a branched alkyl group with at least 3 carbon atoms, with a catalyst containing zeolite and containing rhenium and/or silver, in a liquid phase, thereby changing the position of the carbon atoms of the alkyl group bonding to the aromatic ring of the compound; (3) a step of contacting a halogenated aromatic compound having an alkyl group with at least 3 carbon atoms, with an acid-type catalyst, thereby isomerizing the compound; and (4) a step of treating a mixture of isomers of an aromatic compound having an alkyl group with at least 3 carbon atoms, with a zeolite adsorbent that contains at least one exchangable cation selected from alkali metals, alkaline earth metals, lead, thallium and silver, thereby separating a specific isomer from the isomer mixture through adsorption.
    具有至少 3 个碳原子烷基的芳香族化合物的生产工艺至少包括以下一个步骤: (1) 将含有至少 3 个碳原子的支链烷基的芳香族化合物的起始原料在液相中与含沸石的催化剂在氢存在的情况下接触,从而改变烷基的碳原子与化合物的芳香环键合的位置; (2) 将含有芳香族化合物的起始原料与含沸石和含和/或的催化剂在液相中接触,该芳香族化合物具有至少 3 个碳原子的支链烷基,从而改变烷基碳原子与化合物芳香环键合的位置; (3) 将具有至少 3 个碳原子的烷基的卤代芳香族化合物与酸型催化剂接触,从而使该化合物异构化;以及 (4) 用沸石吸附剂处理具有至少 3 个碳原子的烷基的芳香族化合物的异构体混合物,该沸石吸附剂含有至少一种选自碱属、碱土属、的可交换阳离子,从而通过吸附从异构体混合物中分离出特定的异构体。
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯